| Product name | Dylight 649, Goat Anti-Rabbit IgG |
| Immunogen | Rabbit IgG whole molecule |
| Host | Goat |
| Reactivity | Rabbit |
| Applications | FCM, ICC, IF |
| Applications notes | Optimal working dilutions should be determined experimentally by the investigator. Suggested starting 1:50-1:1000 dilutions for most fluorescent applications. |
| Clonality | Polyclonal |
| Preparation method | Affinity purified using solid phase Rabbit IgG (H&L) with finally > 95% purity based on SDS-PAGE |
| Conjugate | Dylight 649 |
| Formulation | Liquid solution |
| Features & Benefits | DyLight fluorescent dyes are a new family of dyes with improved brightness and photostability). They are better than or comparable to the best fluorescent dyes from other companies). The detection level of any fluorophore-antibody conjugate depends on brightness and photostability of the dye; antibody activity, specificity, and cross-reactivity; and the optimal moles of dye per antibody). A molar saturation curve vs fluorescence intensity, antibody activity, background level, and/or other parameters has been established for each dye to optimize the level of antibody detection and minimize background). DyLight fluorescent dyes are highly water soluble and remain fluorescent from pH 4 to pH 9). |
| Storage buffer | Liquid in PBS, pH 7.4, containing 0.02% Sodium Azide as preservative, 1% BSA as stablizer and 50% Glycerol. |
| Storage instructions | Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing. |
| Shipping | Gel pack with blue ice. |
| Precautions | The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product. |
| Background | Abbkine secondary antibodies are available conjugated to enzyme, biotin or fluorophore for use in a variety of antibody-based applications including Western Blot, ImmunoHistoChemistry, ImmunoFluorescence, Flow Cytometry and ELISA. We offer high quality secondary antibodies from goat, rabbit and donkey sources for your each application. Serum adsorbed secondary antibodies are also available and are recommended for use with immunoglobulin-rich samples. |
| Others | The antibody reacts with whole molecule rabbit IgG. It also reacts with heavy chains of rabbit IgG, and light chains of all other rabbit immunoglobulins. It has no reactivity on non-immunoglobulin serum proteins, while it may cross-react with immunoglobulins from other species. |
Fig.1. DyLight fluorescent dyes are a new family of dyes with improved brightness. DyLight 488-antibody conjugates are brighter than Cy2 and FITC conjugates and similar in brightness to Alexa Fluor 488 conjugates. DyLight 549-antibody conjugates shows brighter influoresence than TRITC conjugates. Also, DyLight 594-antibody conjugates are noticeably brighter than Alexa 594 conjugates, and much brighter and more water soluble than Texas Red conjugates.
Fig.2. DyLight fluorescent dyes show improved photostability as well. DyLight 488 conjugates fade less than FITC and Cy2 conjugates in mounting media indicating that the DyLight 488 molecule is inherently more photostable in epifluorescence microscopes. DyLight 549 conjugates are about as photostable as Alexa 555 conjugates and slightly more photostable than Cy3 conjugates.
Fig.3. To use the DyLight Fluors with fluorescent imagers, use a spectral line of the blue laser diode for DyLight 405, a cyan (488 nm) laser for DyLight 488, a green (526 nm) laser for DyLight 550 and 594, and a red (633 nm) laser for DyLight 633 and 650. The DyLight 680, 755 and 800 fluors are compatible with laser- and filter-based infrared imaging instruments that emit in the 700 nm, 750 nm and 800 nm region of the spectrum, respectively.
Author:P Pan, W Ge, Z Lei, Y Liu, Z Guan, L Chen Publication name:signal transduction and targeted therapy IF:39
Author:Shuai, Yajun, et al. Publication name:Advanced Materials IF:26.8
Author:Chen, Zhuo, et al. Publication name:Journal of Extracellular Vesicles IF:14.5
Author:Zhang LJ, Xia L, Liu SL, et al Publication name:ACS Nano IF:14
Author:Jin, Zhichun, et al. Publication name:International Journal of Oral Science IF:12.2
Author:Wu QM, Liu SL, Chen G, et al Publication name:Small IF:10
Author:王慧丰 Publication name:Frontiers in Molecular Neuroscience 9 (2016) IF:9.5
Author:Zhang G, Xue H, Sun D, Yang S, Tu M, Zeng R, Publication name:Acta Biomater IF:9
Author:C Zhang, P Nie, C Zhou Publication name:Cell Death & Disease IF:8
Author:Chen, Wenxian, et al. Publication name:British Journal of Pharmacology IF:7.7
Author:Xiang Q, Wu J, Zhou Y Publication name:MICROBIOLOGICAL RESEARCH IF:7
Author:X Xu, DD Zhang, P Kong, YK Gao, XF Huang, Y Song, ... Publication name:Cancer Cell Int IF:6.9
Author:Pin Wan, Qi Zhang, Weiyong Liu, et al Publication name:FASEB JOURNAL, 17 Jan 2019 IF:6
Author:Guo H, Ma R, Zhang Y, et al Publication name:Inflammopharmacology IF:6
Author:Xu, Jianguo, et al Publication name:Cancer Cell International IF:6
Author:Liu W, Xing J, Tang X, Sheng X, Chi H, Zhan W, Publication name:Front Immunol IF:5
Author:Wang L, Lu Z, Teng Y, et al Publication name:The FASEB Journal IF:5
Author:Cheng P, Wei H Z, Chen H W, et al Publication name:Journal of cellular and molecular medicine IF:5
Author:F Deng, G Xu, Z Cheng Publication name:Frontiers in Immunology IF:5
Author:A Li, W Wang, Y Wang Publication name:Frontiers in Immunology IF:5
Author:Yang, Jun, et al. Publication name:Archives of Biochemistry and Biophysics IF:5
Author:Man Q W, Li R F, Bu L L, et al. Publication name:Journal of Cellular and Molecular Medicine IF:5
Author:J Hao, Y Chen, M Zhu, Y Zhao, K Zhang, X Xu Publication name:Gels IF:5
Author:J Xing, W Liu, X Tang, X Sheng, H Chi Publication name:Front Immunol IF:5
Author:A Luo, S Li, X Wang, Z Xie, S Li, D Hua Publication name:Journal of Molecular Neuroscience IF:4.5
Author:Huang, Yinpei, et al. Publication name:Neurochemistry International IF:4
Author:Li Guo, Lu Yang, Yu Qi Publication name:Microorganisms IF:4
Author:Jin X, Wang D, Lei M, Guo Y, Cui Y, Chen F, Sun W, Chen X, Publication name:J Transl Med IF:4
Author:Ma, Kang, et al. Publication name:Neurochemical Research IF:3.8
Author:Wenjuan Sun, Yongping Xu, Qian Xin, et al Publication name:Pregnancy Hypertens IF:3
Author:Zihan Zheng,Bo Wang ,Xiaohan Lv Publication name:Exp Cell Res IF:3
Author:Li W, Dong Y, Dong Q, Sun H, Zhang Y, Wang Z Publication name:Eur J Neurosci IF:3
Author:YN Zhou, L Jiang, Y Zhang, CN Zhou, H Yang, ... Publication name:Oncol Lett IF:2.3
Author:Ren X, Li L, Wu J, Lin K, He Y, Bian L Publication name:Oncol Lett IF:2
Author:W Meng, Q Huang, R Zhang, J Shen, D Xie, C Xu, L Liu Publication name:The international journal of biochemistry & cell biology IF:1.3
Author:Song W, Wang F, Li X Publication name:Ginekologia Polska IF:1
Author:C Yin, X Jia, Q Zhao Publication name:Materials Science and Engineering IF:1
Author:Y Zhang, Y Luo, Z Xiao Publication name:researchsquare IF:
Author:H Xie, Y Tian, Z Li, K Wang, R Li, S Yi, A Chen, J Chen Publication name:Research Square IF:
Author:Y Li, Y Liu, H Xiao, F Liao, M Shen, W Ge, L Chen, M Li Publication name:SSRN IF:
Author:Pin Wan, Qi Zhang, et al Publication name:bioRxiv IF:/
Author:Zhu, Chang-Lei, et al. Publication name: IF:
Author:Chen, Yihao, et al. Publication name:The FEBS Journal IF:
Author:Huang, Mengjun, et al. Publication name:Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease IF:
You must be logged in to post a review.
Reviews
There are no reviews yet.